Jim Plante

Jim Plante is an accomplished entrepreneur and executive with extensive experience in health technology and investment sectors. Since October 2017, Jim has served as the CEO, Chairman, and Founder of Klotho Therapeutics, Inc., focusing on developing human Klotho protein to address kidney diseases and challenges related to aging. In addition, Jim is the CEO and Founder of Intelligent Medicine Exchange (IMX) and Managing Partner and Founder of Thynk Capital. As a member of TIGER 21 and founder of the Foundation for Kidney Transplant Research, Jim actively contributes to various initiatives. Other notable roles include serving as a Seed Investor in IVIVA Medical Inc. and previously as a member of the International Trade Advisory Committee for the U.S. Department of Commerce. Jim's entrepreneurial journey includes founding and leading Pathway Genomics Corporation and SmartDrive Systems, both of which achieved significant market success.